Systematic Review of Racial Disparities in Clozapine Prescribing
J. Corey Williams, MD, a graduate of the Yale Psychiatry Residency Program, collaborated with Cenk Tek, MD, Associate Professor of Psychiatry and Vinod Srihari, MD, Professor of Psychiatry to conduct a systematic review of published evidence on clozapine prescribing disparities across racial and ethnic categories.Source: Schizophrenia Research
Colloquium will unify knowledge about mental health across disciplines
The first-ever Yale Mental Health Colloquium will bring together leading scholars in the fields of architecture, business, economics, education, law, neuroscience, psychiatry, public health, social work, and technology for a half-day conversation on the topic.
Researchers evaluate economics of Specialized Treatment Early in Psychosis (STEP) clinic at Yale
Yale researchers have contributed to a paper published in The Journal of Mental Health Policy and Economics that studies the economic advantages to patients and third-party payers offered by the Specialized Treatment Early in Psychosis (STEP) clinic at Yale.
Study suggests new way to treat people after first schizophrenia episode
Quickly identifying people who have suffered a first schizophrenic episode and treating them with coordinated, sustained services sharply boosts their chances of leading productive lives, according to a major study being published October 20. And the treatment can be provided in a typical community mental health setting, the researchers concluded.Source: The Washington Post
Video abstract: First-episode services for psychotic disorders
The Specialized Treatment Early in Psychosis (STEP) program has completed the first experimental study in the U.S. demonstrating the effectiveness of a first-episode service in improving outcomes for psychotic disorders. In this video, Dr. Vinod Srihari discusses the results.Source: YouTube
"Mindmap" launches at STEP
After demonstrating quietly through several years of research that clinical care at STEP—Specialized Treatment in Early Psychosis—is effective, Vinod Srihari, MD and his team are stepping out in a more public way with Mindmap, a public information campaign aimed at improving early detection of psychotic illness.
New program reduces hospitalizations for youth with psychosis
Providing coordinated care to young people who experience their first psychotic episode reduces hospitalization costs and helps patients continue to work and go to school, according to a new study scheduled to appear online Feb. 2 in the journal Psychiatric Services.
STEP reopens, offering early intervention for psychosis
STEP, the program for Specialized Treatment in Early Psychosis, has reopened its clinical service to new admissions, addressing a critical public health gap by offering first-class care to individuals ages 16-35 in the early stages of psychotic illness.
Moderating the Relationship Between Ulcerative Colitis and Crohn’s Disease and Symptoms of PTSD
Alexandra Fuss, PhD, assistant professor of psychiatry, is first author of a paper in Journal of Clinical Gastroenterology that examines whether inflammatory bowel disease (IBD) patients endorse clinically significant symptoms of post-traumatic stress disorder (PTSD), and tests whether remission status and remission expectations effectively moderate the relationship between endorsements of PTSD symptoms and aspects of IBD.Source: Journal of Clinical Gastroenterology
Ketamine infusions improve symptoms of depression, anxiety and suicidal ideation, study says
People who got intravenous ketamine at three private ketamine infusion clinics had "significant improvement" in symptoms of depression, anxiety and suicidal ideation, according to a new study by Gerard Sanacora, PhD, MD George D. and Esther S. Gross Professor of Psychiatry, published in the Journal of Clinical Psychiatry.Source: CNN
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
COVID-19 patients with substance use disorders had greater likelihood of requiring critical interventions, such as ICU admission and ventilatory support. Substance use disorders and psychiatric diagnoses were also associated with a longer duration of hospitalization and greater number of hospital admissions.Source: The Journal of Clinical Psychiatry
Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans
Group cognitive processing therapy (CPT) was associated with a slightly smaller reduction of PTSD symptom severity than individual CPT or prolonged exposure (PE) in veterans at the end of residential treatment. There were no differences at 4-month follow-up.Source: Psychological Medicine
Association of Distress Due to Systemic Racism and Racial Disparities With Psychopathology and Suicidal Ideation Among US Veterans During the COVID-19 Pandemic
A team of Yale Psychiatry researchers analyzed data from a national sample of US veterans to examine the prevalence of perceived systemic racism and racial disparities in COVID-19–related health outcomes and the association of racism-related distress with internalizing and externalizing psychopathology and suicidal ideation during the pandemic.Source: The Journal of Clinical Psychiatry
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.